King's College London

Research portal

Cardiac Myosin-Binding Protein C to diagnose Acute Myocardial Infarction in the pre-hospital setting

Research output: Contribution to journalArticle

Thomas Edward Kaier, Carsten Stengaard, Jack Marjot, Jacob Thørsted Sørensen, Bashir Alaour, Stavroula Stavropoulou-Tatla, Christian Juhl Terkelsen, Luke Williams, Kristian Thygesen, Ekkehard Weber, Michael Stephen Marber, Hans Erik Bøtker

Original languageEnglish
Article numbere013152
Pages (from-to)e013152
JournalJournal of the American Heart Association
Issue number15
Accepted/In press8 Jul 2019
Published6 Aug 2019


King's Authors


Background: Early triage is essential to improve outcome in patients with suspected Acute Myocardial Infarction (AMI). This study investigated whether cardiac myosin-binding protein C (cMyC), a novel biomarker of myocardial necrosis, can aid early diagnosis of AMI and risk stratification. Methods and Results: cMyC and hs-cTnT were retrospectively quantified in blood samples obtained by ambulance-based paramedics in a prospective, diagnostic cohort study. Patients with ongoing or prolonged periods of chest discomfort, acute dyspnoea in the absence of known pulmonary disease, or clinical suspicion of AMI were recruited. Discrimination power was evaluated by calculating the Area under the Receiver-operating characteristics curve; diagnostic performance was assessed at pre-defined thresholds. Diagnostic nomograms were derived & validated using bootstrap resampling in logistic regression models. 776 patients with median age 68 [58;78] were recruited. AMI was the final adjudicated diagnosis in 22%. Median symptom to sampling time was 70 minutes. cMyC concentration in patients with AMI was significantly higher than with other diagnoses: 98 [43;855] vs 17 [9;42] ng/L. Discrimination power for AMI was better with cMyC than with hs-cTnT: AUC 0.839 vs 0.813 (p=0.005). At a previously published rule-out threshold (10 ng/L), cMyC reaches 100% sensitivity and NPV in patients after 2 hours of symptoms. In logistic regression analysis, cMyC is superior to hs-cTnT and was used to derive diagnostic and prognostic nomograms to evaluate risk of AMI and death. Conclusions: In patients undergoing blood draws very early after symptom onset, cMyC demonstrates improved diagnostic discrimination of AMI and could significantly improve the early triage of patients with suspected AMI.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454